Data Foundry

Drug recalls 2017

Paroxetine tablets USP — Class II drug recall D-1137-2017

Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2017-09-20, distributed nationwide. Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Recall numberD-1137-2017
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmZydus Pharmaceuticals USA Inc, Pennington, NJ, United States
Recall initiated2017-08-18
Classified2017-09-11
Reported by FDA2017-09-20
Terminated2020-01-06
DistributedNationwide (US)
Quantity44,800 bottles
NDC68382-0001, 68382-0001-01, 68382-0001-05, 68382-0001-06, 68382-0001-10, 68382-0001-16, 68382-0097, 68382-0097-01, 68382-0097-05, 68382-0097-06, 68382-0097-10, 68382-0097-16, 68382-0098, 68382-0098-01, 68382-0098-05, 68382-0098-06, 68382-0098-10, 68382-0098-16, 68382-0099, 68382-0099-01, 68382-0099-05, 68382-0099-06, 68382-0099-10, 68382-0099-16
Lot numbers03/19, Z701133

Product

Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8

Reason for recall

Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1137-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.